Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

The benthic community of the Laurentian Great Lakes: analysis of spatial gradients and temporal trends from 1998-2014.

Burlakova LE, Barbiero RP, Karatayev AY, Daniel SE, Hinchey EK, Warren GJ.

J Great Lakes Res. 2018 Aug;44(4):600-617. doi: 10.1016/j.jglr.2018.04.008.

2.

Chronic stress induces cell type-selective transcriptomic and electrophysiological changes in the bed nucleus of the stria terminalis.

Daniel SE, Menigoz A, Guo J, Ryan SJ, Seth S, Rainnie DG.

Neuropharmacology. 2019 May 15;150:80-90. doi: 10.1016/j.neuropharm.2019.03.013. Epub 2019 Mar 14.

PMID:
30878403
3.
4.

[Determinants of neonatal serum calcium in a peripheral maternity in Abidjan].

Konan DJ, Amon-Tanoh-Dick F, Aka J, Daniel SE.

Pan Afr Med J. 2015 Apr 21;20:390. doi: 10.11604/pamj.2015.20.390.6138. eCollection 2015. French. No abstract available.

5.

Stress Modulation of Opposing Circuits in the Bed Nucleus of the Stria Terminalis.

Daniel SE, Rainnie DG.

Neuropsychopharmacology. 2016 Jan;41(1):103-25. doi: 10.1038/npp.2015.178. Epub 2015 Jun 22. Review.

6.

Evidence of a breakdown of corticostriatal connections in Parkinson's disease.

Stephens B, Mueller AJ, Shering AF, Hood SH, Taggart P, Arbuthnott GW, Bell JE, Kilford L, Kingsbury AE, Daniel SE, Ingham CA.

Neuroscience. 2005;132(3):741-54.

PMID:
15837135
7.

Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis.

Zijlmans JC, Daniel SE, Hughes AJ, Révész T, Lees AJ.

Mov Disord. 2004 Jun;19(6):630-40.

PMID:
15197700
8.

The L-dopa response in vascular parkinsonism.

Zijlmans JC, Katzenschlager R, Daniel SE, Lees AJ.

J Neurol Neurosurg Psychiatry. 2004 Apr;75(4):545-7.

9.

Accuracy of clinical diagnosis of progressive supranuclear palsy.

Osaki Y, Ben-Shlomo Y, Lees AJ, Daniel SE, Colosimo C, Wenning G, Quinn N.

Mov Disord. 2004 Feb;19(2):181-9.

PMID:
14978673
10.

Alteration in alpha-synuclein mRNA expression in Parkinson's disease.

Kingsbury AE, Daniel SE, Sangha H, Eisen S, Lees AJ, Foster OJ.

Mov Disord. 2004 Feb;19(2):162-70.

PMID:
14978671
11.

Do published criteria improve clinical diagnostic accuracy in multiple system atrophy?

Osaki Y, Wenning GK, Daniel SE, Hughes A, Lees AJ, Mathias CJ, Quinn N.

Neurology. 2002 Nov 26;59(10):1486-91.

PMID:
12455559
12.

Pathological, clinical and genetic heterogeneity in progressive supranuclear palsy.

Morris HR, Gibb G, Katzenschlager R, Wood NW, Hanger DP, Strand C, Lashley T, Daniel SE, Lees AJ, Anderton BH, Revesz T.

Brain. 2002 May;125(Pt 5):969-75.

PMID:
11960887
13.

The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service.

Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ.

Brain. 2002 Apr;125(Pt 4):861-70.

PMID:
11912118
14.

Sequence analysis of tau in familial and sporadic progressive supranuclear palsy.

Morris HR, Katzenschlager R, Janssen JC, Brown JM, Ozansoy M, Quinn N, Revesz T, Rossor MN, Daniel SE, Wood NW, Lees AJ.

J Neurol Neurosurg Psychiatry. 2002 Mar;72(3):388-90.

15.

Two large British kindreds with familial Parkinson's disease: a clinico-pathological and genetic study.

Nicholl DJ, Vaughan JR, Khan NL, Ho SL, Aldous DE, Lincoln S, Farrer M, Gayton JD, Davis MB, Piccini P, Daniel SE, Lennox GG, Brooks DJ, Williams AC, Wood NW.

Brain. 2002 Jan;125(Pt 1):44-57.

PMID:
11834592
16.

What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. 1992.

Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ.

Neurology. 2001 Nov;57(10 Suppl 3):S34-8. No abstract available.

PMID:
11775598
17.

Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease.

Hughes AJ, Daniel SE, Lees AJ.

Neurology. 2001 Oct 23;57(8):1497-9.

PMID:
11673599
18.

A clinical and pathological study of motor neurone disease on Guam.

Morris HR, Al-Sarraj S, Schwab C, Gwinn-Hardy K, Perez-Tur J, Wood NW, Hardy J, Lees AJ, McGeer PL, Daniel SE, Steele JC.

Brain. 2001 Nov;124(Pt 11):2215-22.

PMID:
11673323
19.

Case with both multiple system atrophy and primary progressive multiple sclerosis with discussion of the difficulty in their differential diagnosis.

Chuang C, Kocen RS, Quinn NP, Daniel SE.

Mov Disord. 2001 Mar;16(2):355-8. No abstract available.

PMID:
11295795
20.

Neuronal intranuclear inclusion disease and juvenile parkinsonism.

O'Sullivan JD, Hanagasi HA, Daniel SE, Tidswell P, Davies SW, Lees AJ.

Mov Disord. 2000 Sep;15(5):990-5.

PMID:
11009211
21.

Characterisation of isolated alpha-synuclein filaments from substantia nigra of Parkinson's disease brain.

Crowther RA, Daniel SE, Goedert M.

Neurosci Lett. 2000 Oct 6;292(2):128-30.

PMID:
10998565
22.

Apolipoprotein E epsilon4 allele has no effect on age at onset or duration of disease in cases of frontotemporal dementia with pick- or microvacuolar-type histology.

Pickering-Brown SM, Owen F, Isaacs A, Snowden J, Varma A, Neary D, Furlong R, Daniel SE, Cairns NJ, Mann DM.

Exp Neurol. 2000 Jun;163(2):452-6.

PMID:
10833320
23.

What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease?

Wenning GK, Ben-Shlomo Y, Hughes A, Daniel SE, Lees A, Quinn NP.

J Neurol Neurosurg Psychiatry. 2000 Apr;68(4):434-40.

24.

Organochlorine insecticides in substantia nigra in Parkinson's disease.

Corrigan FM, Wienburg CL, Shore RF, Daniel SE, Mann D.

J Toxicol Environ Health A. 2000 Feb 25;59(4):229-34.

PMID:
10706031
25.

Is Parkinson's disease a primary olfactory disorder?

Hawkes CH, Shephard BC, Daniel SE.

QJM. 1999 Aug;92(8):473-80. Review.

PMID:
10627864
26.

The tau gene A0 polymorphism in progressive supranuclear palsy and related neurodegenerative diseases.

Morris HR, Janssen JC, Bandmann O, Daniel SE, Rossor MN, Lees AJ, Wood NW.

J Neurol Neurosurg Psychiatry. 1999 May;66(5):665-7.

27.

Basal ganglia neuronal nitric oxide synthase mRNA expression in Parkinson's disease.

Eve DJ, Nisbet AP, Kingsbury AE, Hewson EL, Daniel SE, Lees AJ, Marsden CD, Foster OJ.

Brain Res Mol Brain Res. 1998 Dec 10;63(1):62-71.

PMID:
9838046
28.

Conjugates of catecholamines with cysteine and GSH in Parkinson's disease: possible mechanisms of formation involving reactive oxygen species.

Spencer JP, Jenner P, Daniel SE, Lees AJ, Marsden DC, Halliwell B.

J Neurochem. 1998 Nov;71(5):2112-22.

29.

Clinical usefulness of magnetic resonance imaging in multiple system atrophy.

Schrag A, Kingsley D, Phatouros C, Mathias CJ, Lees AJ, Daniel SE, Quinn NP.

J Neurol Neurosurg Psychiatry. 1998 Jul;65(1):65-71.

30.

Frontal cortical synaptophysin in Lewy body diseases: relation to Alzheimer's disease and dementia.

Hansen LA, Daniel SE, Wilcock GK, Love S.

J Neurol Neurosurg Psychiatry. 1998 May;64(5):653-6.

31.

Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease.

Banati RB, Daniel SE, Blunt SB.

Mov Disord. 1998 Mar;13(2):221-7.

PMID:
9539333
32.

Multiple-system atrophy is genetically distinct from identified inherited causes of spinocerebellar degeneration.

Bandmann O, Sweeney MG, Daniel SE, Wenning GK, Quinn N, Marsden CD, Wood NW.

Neurology. 1997 Dec;49(6):1598-604.

PMID:
9409353
33.

Upregulation of the anti-apoptotic protein Bcl-2 may be an early event in neurodegeneration: studies on Parkinson's and incidental Lewy body disease.

Marshall KA, Daniel SE, Cairns N, Jenner P, Halliwell B.

Biochem Biophys Res Commun. 1997 Nov 7;240(1):84-7.

PMID:
9367887
34.

A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease.

Alam ZI, Daniel SE, Lees AJ, Marsden DC, Jenner P, Halliwell B.

J Neurochem. 1997 Sep;69(3):1326-9.

35.

Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra.

Alam ZI, Jenner A, Daniel SE, Lees AJ, Cairns N, Marsden CD, Jenner P, Halliwell B.

J Neurochem. 1997 Sep;69(3):1196-203.

36.

Neuronal loss and plasticity in the supraoptic nucleus in Parkinson's disease.

Ansorge O, Daniel SE, Pearce RK.

Neurology. 1997 Aug;49(2):610-3.

PMID:
9270609
37.

Tau protein in the glial cytoplasmic inclusions of multiple system atrophy can be distinguished from abnormal tau in Alzheimer's disease.

Cairns NJ, Atkinson PF, Hanger DP, Anderton BH, Daniel SE, Lantos PL.

Neurosci Lett. 1997 Jul 11;230(1):49-52.

PMID:
9259461
38.

Mitochondrial respiratory chain function in multiple system atrophy.

Gu M, Gash MT, Cooper JM, Wenning GK, Daniel SE, Quinn NP, Marsden CD, Schapira AH.

Mov Disord. 1997 May;12(3):418-22.

PMID:
9159739
39.

Olfactory dysfunction in Parkinson's disease.

Hawkes CH, Shephard BC, Daniel SE.

J Neurol Neurosurg Psychiatry. 1997 May;62(5):436-46.

40.

Mitochondrial DNA polymorphisms in pathologically proven Parkinson's disease.

Bandmann O, Sweeney MG, Daniel SE, Marsden CD, Wood NW.

J Neurol. 1997 Apr;244(4):262-5.

PMID:
9112596
41.

Multiple system atrophy: a review of 203 pathologically proven cases.

Wenning GK, Tison F, Ben Shlomo Y, Daniel SE, Quinn NP.

Mov Disord. 1997 Mar;12(2):133-47.

PMID:
9087971
42.

Down's syndrome and Parkinson's disease.

Hestnes A, Daniel SE, Lees AJ, Brun A.

J Neurol Neurosurg Psychiatry. 1997 Mar;62(3):289. No abstract available.

43.

Apolipoprotein E e4 allele frequency in patients with multiple system atrophy.

Cairns NJ, Atkinson PF, Kovács T, Lees AJ, Daniel SE, Lantos PL.

Neurosci Lett. 1997 Jan 17;221(2-3):161-4.

PMID:
9121689
44.

Amyloid beta-peptide and its relationship with dementia in Lewy body disease.

Jendroska K, Kashiwagi M, Sassoon J, Daniel SE.

J Neural Transm Suppl. 1997;51:137-44.

PMID:
9470134
45.

Glutamate decarboxylase-67 messenger RNA expression in normal human basal ganglia and in Parkinson's disease.

Nisbet AP, Eve DJ, Kingsbury AE, Daniel SE, Marsden CD, Lees AJ, Foster OJ.

Neuroscience. 1996 Nov;75(2):389-406.

PMID:
8931005
46.

Amyloid beta-peptide and the dementia of Parkinson's disease.

Jendroska K, Lees AJ, Poewe W, Daniel SE.

Mov Disord. 1996 Nov;11(6):647-53.

PMID:
8914090
47.
48.

What can artificial neural networks teach us about neurodegenerative disorders with extrapyramidal features?

Litvan I, DeLeo JM, Hauw JJ, Daniel SE, Jellinger K, McKee A, Dickson D, Horoupian DS, Lantos PL, Tabaton M.

Brain. 1996 Jun;119 ( Pt 3):831-9.

PMID:
8673495
49.

Olivopontocerebellar pathology in multiple system atrophy.

Wenning GK, Tison F, Elliott L, Quinn NP, Daniel SE.

Mov Disord. 1996 Mar;11(2):157-62.

PMID:
8684385
50.

Facial dystonia in pathologically proven multiple system atrophy: a video report.

Wenning GK, Quinn NP, Daniel SE, Garratt H, Marsden CD.

Mov Disord. 1996 Jan;11(1):107-9. No abstract available.

PMID:
8771082

Supplemental Content

Loading ...
Support Center